Bob Repella - Info zur Person mit Bilder, News & Links



	CSL Behring

News

(1 - 4 von 19

–alle anzeigen

)

EMA approva la revisione del Riassunto delle ...

www.ad-hoc-news.de

... individuali dei pazienti in terapia con Ig, incluso l'eventuale riduzione di quantità e tempo di infusione", ha detto Bob Repella, ...

COMUNICADO: CSL Behring y Enable Injections lanzan un nuevo...

www.europapress.es

--- CSL Behring firma un acuerdo de desarrollo estratégico con Enable Injections para comercializar un nuevo dispositivo de administración de medicamento

CSL Behring unterzeichnet strategische Entwicklungsvereinbarung mit...

www.ots.at

CSL Behring hat heute bekanntgegeben, dass sein angeschlossenes Unternehmen, die CSL Behring AG aus Bern, Schweiz, und Enable Injections, LLC, aus Franklin,...

finanzen.net - Seite nicht gefunden

www.finanzen.net

Harmony Biosciences erwirbt US-Rechte fr Pitolisant von Bioprojet; 270 Millionen USD durch Eigenkapitalfinanzierung beschafft | Nachricht | finanzen.net

Netzwerk-Profile

LinkedIn: Bob Repella | Professional Profile - LinkedIn

View Bob Repella's profile on LinkedIn, the world's largest professional community. Bob has 1 job listed on their profile. See the complete profile on LinkedIn and discover Bob's connections and jobs at similar companies.

Interessen

(1 - 2 von 6

–alle anzeigen

)

Harmony Biosciences Receives Breakthrough Therapy And Fast Track...

markets.businessinsider.com

... designations for pitolisant from the FDA is welcome news as narcolepsy patients face many challenges," said Harmony's CEO, Bob Repella.

CSL Ltd (CSL.AX) Insider Trading | Reuters.com

www.reuters.com

59, 2013, Executive Vice President - Quality and Business Services. Bob Repella . 58, 2014, Executive Vice President - Global Commercial Operations ...

Private Homepages

Healthcare Trends & Transactions

myemail.constantcontact.com

The new Harmony is helmed by life sciences veteran Bob Repella, the former head of global commercial operations at CSL Behring. Parent Paragon is banking ...

Dokumente zum Namen

(1 - 4 von 7

–alle anzeigen

)

August Connecticut Travelers

www.ctsca.org

In the end, Bob Repella edged out Al Pana for the. HOA award. Congratulations Bob, well shot! It was good to see some faces we haven't seen in a while. Long- time Travelers Kathy and Ted Knapp, Merle Yoder, and. George Parsons couldn't resist our “throwback shoot” of the year. We hope to see them ...

BioSupply Trends Quarterly Online Magazine

www.bstquarterly.com

... to know that there is an FDA-approved, safe and effective treatment option for children,” said Bob Repella, executive vice president of commercial operations ...

Investor R&D Briefing

www.aspecthuntley.com.au

Commercial Opportunities. Bob Repella. • Q&A. - Break -. • Coagulation/Haemophilia. • Clinical Development. Charmaine Gittleson. • Commercial Opportunities. Bob Repella. • Breakthrough Medicines. • CSL112 Clinical Development. Charmaine Gittleson. • CSL112 Commercial Opportunities. Bob Repella.

R&D Investor Briefing CSL Behring

www.cslbehring.com

CSL112 Clinical Development. Charmaine Gittleson. • CSL112 Commercial Opportunities. Bob Repella. • Seqirus R&D. Russell Basser.

Artikel & Meinungen

(1 - 4 von 5

–alle anzeigen

)

U.S. FDA Approves CSL Behring's Berinert® as the First and Only...

money.cnn.com

... safe and effective treatment option for children," says Bob Repella, Executive Vice President, Commercial Operations, CSL Behring.

Anyone know Bill Campbell? | Cafepharma Message Boards | Pharma...

www.cafepharma.com

Any thoughts on this guy/management style?

Fireside Chats At Upcoming BIO International Convention |...

www.researchamerica.org

The first half of has already been a very busy year for the Food and Drug Administration as it finalized and published its new comprehensive set of...

Harmony’s pitolisant granted breakthrough and fast track designations...

www.pbiforum.net

Harmony's CEO Bob Repella added: “Receiving Breakthrough and Fast Track designations for pitolisant from FDA is welcome news as ...

Sonstiges

(1 - 20 von 32

–alle anzeigen

)

Bob Repella | LinkedIn

www.linkedin.com

View Bob Repella's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Bob Repella discover inside connections to recommended job candidates, industry experts, and business partners.

Bob Repella - CEO - Harmony Biosciences, LLC | LinkedIn

www.linkedin.com

View Bob Repella's profile on LinkedIn, the world's largest professional community. Bob has 4 jobs listed on their profile. See the complete profile on LinkedIn ...

Bob Repella on CrowdRise

www.crowdrise.com

The person who created this page is probably preparing something riveting to post about everything they're doing to give back. We recommend you sit at your...

Bob Repella | CSL Behring | United States of America

biography.omicsonline.org

Bob Repella is responsible for a variety of global functions including sales, marketing, commercial development and..

Cephalon appoints Bob Repella as senior vice president of US...

www.firstwordpharma.com

FirstWord Pharma - Gain Access to the Information You Need Track the Companies, Products, and Regulatory Areas of Most...

Bob Repella | CSL Behring | Italy

biography.omicsonline.org

Bob Repella is responsible for a variety of global functions including sales, marketing, commercial development and medical affairs.Mr. Repella joined CSL...

Harmony Biosciences Gains U.S. Rights to Pitolisant, Raises $

www.pharmalive.com

Pitolisant increases the release of the brain chemical histamine to increase a patient’s wakefulness and alertness, according to Harmony. The new Harmony is helmed by life sciences veteran Bob Repella , the former head of …

HREXECsOnTheMove.com @harmonybiosciences.com HREXECsonthemove

www.hrexecsonthemove.com

Looking for Bob Repella, Chief Executive Officer at Harmony Biosciences? Contact Bob today at updated @harmonybiosciences.com email, phone and address here at...

CSL Behring Signs Strategic Agreement With Enable Injections

drug-dev.com

CSL Behring LLC recently announced its affiliate company, CSL Behring AG, of Bern, Switzerland, and Enable Injections, LLC, of Franklin, OH, have

COMUNICADO: Harmony Biosciences adquiere los derechos en Estados...

www.lavanguardia.com

PARIS, October 6, PRNewswire Harmony Biosciences adquiere los derechos en Estados Unidos para Pitolisant de Bioprojet; eleva a 270 millones de...

9100 Verree Rd Philadelphia Pa Address Search Results

www.fastpeoplesearch.com

AKA: Robert Drepella , Robert Repella , R D Repella , R Repella , Robt D Repella , Mr Robert D Repella , Rob Repella , Bob Repella. Related to: Don A Repella ...

FDA Grants Pitolisant Breakthrough, Fast Track Designations in...

www.neurologylive.com

The FDA has granted a Breakthrough Therapy and Fast Track Designation to pitolisant for cataplexy in patients with narcolepsy, as Harmony Biosciences prepares...

▷ CSL Behring unterzeichnet strategische Entwicklungsvereinbarung mit...

www.presseportal.ch

... die Leben retten und verlängern können", sagte Bob Repella, Executive Vice President, Global Commercial Operations, CSL Behring.

Harmony Biosciences Raises $270M in Equity Financing | FinSMEs

www.finsmes.com

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Patient Summit USA | Going International

www.goinginternational.eu

Going International

Harmony Biosciences Gains U.S. Rights to Pitolisant, Raises $

www.biospace.com

Harmony Biosciences Gains U.S. Rights to Pitolisant, Raises $270 Million - read this article along with other careers information, tips and advice on BioSpace

» Harmony Biosciences acquiert les droits US du pitolisant du...

www.mypharma-editions.com

La société biopharmaceutique américaine Harmony Biosciences et l'entreprise pharmaceutique française Bioprojet ont annoncé l'acquisition par Harmony des droits...

Schedule A for ALL Line #'s

docquery.fec.gov

Bob Repella, First Avenue King of Prussia, Pennsylvania , CSL Behring / Senior VP, Commerical Operations, $ semi-monthly,

Schedule A for Line #11AI

docquery.fec.gov

Ursela Reinisch, Valley Forge Circle PH King of Prussia, Pennsylvania , CSL Behring / Director, Regulatory, $ semi-monthly, Bob Repella, First Avenue King of Prussia, Pennsylvania , CSL Behring / Senior VP, Commerical Operations, $ semi-monthly

U.S. FDA Approves Berinert as the First and Only Pediatric Treatment...

haei.org

... and their caregivers, to know that there is a FDA approved, safe and effective treatment option for children,” says Bob Repella, Executive Vice ...

Verwandte Suchanfragen zu Bob Repella

Personen
Vorname "Bob" (6519)
Name "Repella" (12)

sortiert nach Relevanz / Datum

Erweiterte Suche

Dossier exportieren

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Bob Repella Person-Info

Netzwerk-Profile

Private Homepages